NewsRx

Search our medical news database

Anthrax

BioPort working on new vaccine

Published in Vaccine Weekly, April 10th, 2002

An estimated 20 companies, federal organizations and universities are working toward finding a new anthrax vaccine.

So is BioPort Corp., the Lansing, Michigan, company that now is the sole U.S. provider of the existing vaccine. BioPort has worked on a new anthrax vaccine for the past year. Other researchers began as early as 1997.

One of the potential competitors might be ready for human safety trials this summer, but all are likely years away from approval for use.

BioPort just this year received U.S. Food and Drug Administration approval for its renovated labs that make a relatively old, slow-acting vaccine against anthrax. ...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook